What's breaking now, across thousands of outlets.
From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go. But researchers still face a fundamental challenge: getting those therapies to the organs where they are needed most while limiting side effects elsewhere in the body.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
RIYADH — Over 59 percent of Saudi Arabia’s population aged 18 and older engaged in at least 150 minutes of physical activity per week in 2025, according to the General Authority for Statistics…
Toronto, ON, Oct. 01, 2026 (GLOBE NEWSWIRE) — Nox Peptides has announced an expanded focus on research-use peptide compounds in Canada, highlighting BPC-157 and GHK-Cu as part of its ongoing efforts…
A diagnosis, a violent encounter, a jobless future and the death of a parent can appear very different on paper. But behind each statistic is a person forced to make a decision when waiting is no…
At the heart of North America’s “renaissance” in psychedelics "is a vast new supply of funding” from big-money interests, says a top Canadian researcher at Harvard Medical School who spoke at a major…
Devoted Health, a Medicare Advantage insurer and medical group, announced nearly $1.2 billion in fresh funding after enrolling hundreds of thousands of new senior members this year.
